MELBOURNE, Australia, Nov. 8, 2016 /PRNewswire/ -- ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce the global launch of its highly innovative patented DonorCare Needle Guard 2 that took place at the American Association of Blood Banks (AABB) Annual Meeting in Orlando, Florida, the premier event for healthcare professionals in transfusion medicine and cellular therapies.
ITL has been selling the first generation DonorCare Needle Guard for over 15 years and has sold in excess of 200 million units in over 50 countries. First generation DonorCare Needle Guard set a global industry standard for whole blood collection needle guards. The highly innovative DonorCare Needle Guard 2 provides robust functionality with enhanced features including visual confirmation that the needle is safely locked in place, along with an audible click. The DonorCare Needle Guard 2 is designed for safe and fast needle withdrawal, immediately shielding the whole blood collection needle in a secure, one-piece housing thereby reducing potential exposure to needle stick injury. Featuring a simple and user-friendly design, the product requires minimal training and can be easily incorporated into existing processes. ITL BioMedical's efficient product design enables manufacturers to pre-attach DonorCare Needle Guard 2 onto blood bag tubing.